Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Trial, Enrolling Subjects Aged 6 Years to Less Than 18 Years Suffering From Pain Requiring Prolonged Release Opioid Treatment, to Evaluate the Safety and Efficacy of Tapentadol PR Versus Morphine PR, Followed by an Open-label Extension

NCT02151682 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT02151682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02151682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Trial, Enrolling Subjects Aged 6 Years to Less Than 18 Years Suffering From Pain Requiring Prolonged Release Opioid Treatment, to Evaluate the Safety and Efficacy of Tapentadol PR Versus Morphine PR, Followed by an Open-label Extension
Lead sponsor
Grünenthal GmbH
Phase
Phase 2/3
Overall status
Completed
Start date
April 29, 2015
Completion date
October 15, 2018
Enrollment
73 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

pain